- Home
- CRNC vs SAVA Comparison
CRNC vs SAVA Comparison
Compare CRNC & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNC
- SAVA
- Stock Information
- Founded
- CRNC 2020
- SAVA 1998
- Country
- CRNC United States
- SAVA United States
- Employees
- CRNC N/A
- SAVA N/A
- Industry
- CRNC EDP Services
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- CRNC Technology
- SAVA Health Care
- Exchange
- CRNC Nasdaq
- SAVA Nasdaq
- Market Cap
- CRNC 132.5M
- SAVA 135.9M
- IPO Year
- CRNC N/A
- SAVA N/A
- Fundamental
- Price
- CRNC $12.58
- SAVA $2.75
- Analyst Decision
- CRNC Hold
- SAVA Buy
- Analyst Count
- CRNC 8
- SAVA 3
- Target Price
- CRNC $7.61
- SAVA $111.50
- AVG Volume (30 Days)
- CRNC 15.6M
- SAVA 3.4M
- Earning Date
- CRNC 02-04-2025
- SAVA 02-26-2025
- Dividend Yield
- CRNC N/A
- SAVA N/A
- EPS Growth
- CRNC N/A
- SAVA N/A
- EPS
- CRNC N/A
- SAVA N/A
- Revenue
- CRNC $331,504,000.00
- SAVA N/A
- Revenue This Year
- CRNC N/A
- SAVA N/A
- Revenue Next Year
- CRNC $13.35
- SAVA N/A
- P/E Ratio
- CRNC N/A
- SAVA N/A
- Revenue Growth
- CRNC 12.57
- SAVA N/A
- 52 Week Low
- CRNC $2.34
- SAVA $2.23
- 52 Week High
- CRNC $27.50
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- CRNC 54.80
- SAVA 30.54
- Support Level
- CRNC $12.66
- SAVA $2.65
- Resistance Level
- CRNC $14.90
- SAVA $2.83
- Average True Range (ATR)
- CRNC 2.69
- SAVA 0.24
- MACD
- CRNC -0.26
- SAVA 0.59
- Stochastic Oscillator
- CRNC 25.10
- SAVA 52.75
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.